Thiazolidinedione use is associated with reduced risk of Parkinson's disease in patients with diabetes

被引：0
|
作者：
Hussain, S. [1 ]
Singh, A. [1 ]
Baxi, H. [1 ]
Taylor, B. [1 ]
Burgess, J. [1 ]
Antony, B. [1 ]
机构：
[1] Jamia Hamdard, New Delhi, India
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
191
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [31] Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes Mellitus
    Lewis, James D.
    Capra, Angela M.
    Achacoso, Ninah S.
    Ferrara, Assiamira
    Levin, Theodore R.
    Quesenberry, Charles P., Jr.
    Habeli, Laurel A.
    GASTROENTEROLOGY, 2008, 135 (06) : 1914 - 1923
  • [32] Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
    Habib, Zeina A.
    Havstad, Suzanne L.
    Wells, Karen
    Divine, George
    Pladevall, Manel
    Williams, L. Keoki
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02): : 592 - 600
  • [33] Metformin Use Is Associated with Reduced Risk of Heart Failure Events in Patients with Diabetes
    Lanfear, David
    Velez, Mauricio
    Peterson, Edward
    Wells, Karen
    Sabbah, Hani N.
    Williams, L. Keoki
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : S30 - S31
  • [34] Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer's Disease and Parkinson's Disease
    Klinger, Danielle
    Hill, Brian L.
    Barda, Noam
    Halperin, Eran
    Gofrit, Ofer N.
    Greenblatt, Charles L.
    Rappoport, Nadav
    Linial, Michal
    Bercovier, Herve
    VACCINES, 2021, 9 (05)
  • [35] A specific SEPT14 haplotype is associated with a reduced risk for Parkinson's disease
    Orr-Urtreger, A.
    Rozenkrantz, L.
    Gan-Or, Z.
    Gana-Weisz, M.
    Mirelman, A.
    Gurevich, T.
    Bar Shira, A.
    Giladi, N.
    MOVEMENT DISORDERS, 2013, 28 : S394 - S394
  • [36] Risk of Parkinson's Disease in Patients with Diabetes Mellitus and Other Comorbidities in Taiwan
    Lee, Chia-Ju
    Yeh, Yi-Chun
    Liang, Chun-Yu
    Chen, Yen-Yu
    NEUROLOGY, 2016, 86
  • [37] Thiazolidinedione use is not associated with worse cardiovascular outcomes: A study in 28,332 high risk patients with diabetes in routine clinical practice Brief title: Thiazolidinedione use and mortality
    Roussel, Ronan
    Hadjadj, Samy
    Pasquet, Blandine
    Wilson, Peter W. F.
    Smith, Sidney C., Jr.
    Goto, Shinya
    Tubach, Florence
    Marre, Michel
    Porath, Avi
    Krempf, Michel
    Bhatt, Deepak L.
    Steg, P. Gabriel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (04) : 1380 - 1384
  • [38] Diabetes in patients with idiopathic Parkinson's Disease
    Becker, Claudia
    Brobert, Gunnar P.
    Johansson, Saga
    Jick, Susan S.
    Meier, Christoph R.
    DIABETES CARE, 2008, 31 (09) : 1808 - 1812
  • [39] NSAID use and the risk of Parkinson's Disease
    Etminan, M
    Suissa, S
    NEUROLOGY, 2004, 62 (07) : A216 - A216
  • [40] IS METHAMPHETAMINE USE A RISK FOR PARKINSON'S DISEASE?
    Moratalla, R.
    Ares-Santos, S.
    Granado, N.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2016, 11 : S53 - S53
12345